GLP-1 analogues has been shown to enhance cognitive function in control animals [38, 45], to prevent cognitive impairment in models of T2DM [48, 49], and to counteract β-amyloid toxicity in models of AD [43, 51]. The gene discussed is GLP1R; the disease is Cognitive impairment.